Stress And Disease: Describe The Physiologic Effects

Stress And Disease Describe The Physiologic Ef

1. Stress and Disease: Describe the physiologic effects on body systems of increased cortisol levels released during the stress response.

During the stress response, the body activates the hypothalamic-pituitary-adrenal (HPA) axis, leading to increased secretion of cortisol from the adrenal cortex. Cortisol, a glucocorticoid hormone, plays a crucial role in adapting to stress by mobilizing energy reserves, modulating immune responses, and maintaining homeostasis. Elevated cortisol levels influence multiple body systems. In the cardiovascular system, cortisol enhances vasoconstriction, increases heart rate, and elevates blood pressure, preparing the body for a 'fight or flight' response. In the metabolic system, cortisol promotes gluconeogenesis, resulting in increased blood glucose levels necessary for energy amidst stress. It also stimulates lipolysis and proteolysis, providing additional energy sources. In the immune system, cortisol exerts immunosuppressive effects by inhibiting the production of pro-inflammatory cytokines and reducing lymphocyte proliferation, which can impair immune defense over prolonged periods. The musculoskeletal system may experience muscle protein breakdown due to the catabolic effects of cortisol. Additionally, cortisol influences the nervous system, contributing to mood alterations, cognitive changes, and stress perception. Chronic elevation of cortisol levels, however, can have detrimental effects such as hypertension, insulin resistance, osteoporosis, and increased susceptibility to infections, highlighting the importance of balanced cortisol regulation in maintaining overall health.

2. Define dementia of Alzheimer type (DAT) and describe the pathophysiology, clinical manifestations, evaluation, and treatment.

Dementia of Alzheimer type (DAT), commonly known as Alzheimer's disease, is a progressive neurodegenerative disorder characterized by gradual decline in cognitive functions, particularly memory, reasoning, and executive functions. The pathophysiology involves the accumulation of amyloid-beta plaques and neurofibrillary tangles composed of hyperphosphorylated tau protein within the brain. These pathological features lead to neuronal injury, synaptic loss, and brain atrophy, especially in the hippocampus and cortex. The cholinergic neurons that are essential for cognitive processes are significantly affected, resulting in decreased acetylcholine levels. Clinically, patients initially present with short-term memory impairment, progressing to difficulties with language, disorientation, and impaired reasoning. As the disease advances, individuals may exhibit behavioral disturbances, agitation, and loss of independence. Diagnostic evaluation includes clinical assessment, neuropsychological testing, and neuroimaging techniques such as MRI or PET scans to identify characteristic atrophy and metabolic changes. Current treatments aim to alleviate symptoms rather than cure the disease; cholinesterase inhibitors (e.g., donepezil) and NMDA receptor antagonists (e.g., memantine) are commonly prescribed to enhance cognitive function. Lifestyle modifications, cognitive therapy, and management of comorbidities are also vital components of care to improve quality of life.

3. Discuss the pathophysiology of cerebrovascular accidents (CVAs)—thrombotic, embolic, hemorrhagic, and lacunar—their incidence and prevalence, clinical manifestations, evaluation, and treatment.

Cerebrovascular accidents (CVAs), or strokes, are medical emergencies resulting from the disruption of blood flow to parts of the brain, leading to ischemia and neuronal injury. Four main types include thrombotic, embolic, hemorrhagic, and lacunar strokes. Thrombotic strokes occur due to the formation of a blood clot within a cerebral artery, often associated with atherosclerosis. Embolic strokes result from an embolus—often a thrombus originating elsewhere, such as the heart—lodging in cerebral arteries. Hemorrhagic strokes involve bleeding into brain tissue caused by ruptured blood vessels, commonly due to hypertension or aneurysms. Lacunar strokes are small, subcortical infarcts resulting from occlusion of small penetrating arteries, frequently linked to hypertension and diabetes. The incidence varies with age, but strokes are a leading cause of disability worldwide, with ischemic strokes accounting for approximately 87% of cases, and hemorrhagic strokes comprising about 13%. Clinical manifestations include sudden weakness, numbness, speech difficulties, vision changes, and loss of coordination. Evaluation involves neurological examination, neuroimaging (CT or MRI), carotid ultrasonography, and cardiac assessment. Treatment depends on the stroke type; ischemic strokes may benefit from thrombolytic therapy (e.g., tPA) if administered promptly, while hemorrhagic strokes require blood pressure management, surgical intervention, and supportive care. Prevention strategies focus on controlling risk factors such as hypertension, diabetes, and atrial fibrillation.

Paper For Above instruction

Stress triggers a cascade of physiological responses involving multiple body systems, primarily mediated by the hypothalamic-pituitary-adrenal (HPA) axis. When an individual perceives a stressor, the hypothalamus secretes corticotropin-releasing hormone (CRH), stimulating the anterior pituitary to release adrenocorticotropic hormone (ACTH). Subsequently, the adrenal cortex is prompted to produce and secrete cortisol, the primary stress hormone. Elevated cortisol levels influence several body systems, facilitating immediate survival but potentially causing adverse effects if sustained excessively.

In the cardiovascular system, increased cortisol enhances vasoconstriction and cardiac contractility, leading to elevated blood pressure and heart rate. Such changes prepare an individual for 'fight or flight' but may contribute to hypertension if chronic. The metabolic effects of cortisol include stimulating gluconeogenesis in the liver, raising blood glucose levels necessary for energy. It also promotes lipolysis and muscle proteolysis, providing alternative energy sources but risking muscle wasting over prolonged periods. Regarding the immune system, cortisol exerts immunosuppressive effects by inhibiting cytokine production and lymphocyte proliferation, which can diminish immune responses and increase susceptibility to infections. The musculoskeletal system may suffer from muscle breakdown due to the catabolic effects of cortisol, while the nervous system may experience mood swings, cognitive impairment, and increased perception of stress. Chronic activation of these pathways can lead to health issues such as hypertension, insulin resistance, osteoporosis, and increased infection risk, underlying the importance of balanced cortisol regulation for overall well-being.

Alzheimer's disease, representing the most common form of dementia, reflects a progressive neurodegenerative process characterized by cognitive decline that impacts daily functioning. The disease's hallmark pathophysiological features include the accumulation of amyloid-beta plaques outside neurons and neurofibrillary tangles within neurons, composed of hyperphosphorylated tau protein. These abnormal deposits lead to neuronal injury, synaptic loss, and cerebral atrophy, especially in the hippocampus and cerebral cortex. The cholinergic system, pivotal for memory and learning, is significantly compromised, resulting in decreased acetylcholine production. Clinically, patients initially experience short-term memory deficits, progressing to impairments in language, visuospatial abilities, and executive functions. Behavioral and psychological symptoms such as agitation, depression, and apathy often accompany cognitive decline.

Diagnosis involves thorough clinical assessment, neuropsychological testing, and neuroimaging, including MRI, which reveals characteristic cortical and hippocampal atrophy. PET scans can detect metabolic changes, and cerebrospinal fluid analysis may show increased tau and decreased amyloid-beta levels. While no cure exists, symptomatic treatments aim to improve cognitive function and slow decline. Cholinesterase inhibitors like donepezil and NMDA receptor antagonists such as memantine are commonly used. In addition to pharmacotherapy, lifestyle modifications, cognitive training, physical activity, and management of comorbid conditions contribute to managing symptoms and improving quality of life in affected individuals.

Cerebrovascular accidents (CVAs) are abrupt neurological deficits resulting from an interruption of cerebral blood flow attributable to ischemic or hemorrhagic mechanisms. Ischemic strokes include thrombotic strokes, caused by thrombosis at the site of atherosclerotic plaques within cerebral arteries, and embolic strokes, resulting from emboli originating elsewhere, such as cardiac thrombi in atrial fibrillation. Hemorrhagic strokes occur due to bleeding into brain tissue from ruptured blood vessels, often secondary to hypertension or vascular anomalies. Lacunar strokes are small infarcts in deep brain regions supplied by penetrating arteries, frequently linked to hypertension and diabetes mellitus.

The incidence of stroke varies globally but is a leading cause of long-term disability and death. Ischemic strokes represent approximately 87% of all strokes, while hemorrhagic strokes comprise about 13%. Clinical presentations typically include sudden weakness, numbness, speech difficulties (aphasia), visual disturbances, dizziness, and loss of coordination or balance.

Evaluation involves a detailed neurological examination and neuroimaging—Computed Tomography (CT) scans are essential for differentiating ischemic from hemorrhagic strokes. Magnetic resonance imaging (MRI) provides further detail on infarct size and location. Vascular studies and cardiac assessments help identify embolic sources. Treatment strategies depend on stroke type; thrombolytic agents like tissue plasminogen activator (tPA) are effective in eligible ischemic stroke patients if administered within a critical time window. Hemorrhagic strokes often require blood pressure control, surgical intervention, and supportive care. Secondary prevention emphasizes controlling risk factors such as hypertension, atrial fibrillation, hyperlipidemia, smoking cessation, and lifestyle modification.

References

• Alzheimer's Association. (2021). 2021 Alzheimer's disease facts and figures. Alzheimer's & Dementia, 17(3), 327-406.
• Buckley, C. T., & Kelleher, M. (2018). The pathophysiology of stroke. Irish Journal of Medical Science, 187(4), 1055-1061.
• Halter, J. B. (2019). Stress and physical health. In P. J. Corr (Ed.), The Routledge handbook of health psychology (pp. 229-245). Routledge.
• Kandel, E. R., Schwartz, J. H., & Jessell, T. M. (2013). Principles of neural science (5th ed.). McGraw-Hill.
• Norrving, B., & Rice, K. A. (2019). Epidemiology of stroke. Circulation Research, 124(2), 259-270.
• Petersen, R. C. (2017). Clinical diagnosis of Alzheimer’s disease. Neurobiology of Aging, 52, S15–S21.
• Sumner, A., & Jayaweera, A. (2020). Understanding cerebrovascular disease. Journal of Stroke, 22(1), 1-12.
• Teng, E. L., & Beekly, D. (2019). Diagnosing Alzheimer’s disease. Clinics in Geriatric Medicine, 35(3), 445-461.
• Wardlaw, J. M., et al. (2019). Recurrent stroke prevention: An overview. The Lancet Neurology, 18(8), 613–632.
• World Health Organization. (2018). Global status report on noncommunicable diseases 2018. WHO.